Promoting and facilitating strategies to improve cardiovascular health worldwide

Meeting Highlights

From the 26th Annual Scientific Meeting of the ISCP – Singapore



Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar



ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



Low income tied to mortality risk after STEMI hospitalization

Posted on May 22, 2022

ATLANTA — Patients with low household income who presented with STEMI faced greater risk for inpatient mortality, longer hospital stay and need... more

Ozanimod produces favorable long-term cardiac safety profile in UC, MS

Posted on May 21, 2022

SAN DIEGO — Minimal long-term cardiac safety findings were reported with ozanimod treatment in patients with ulcerative colitis and relapsing multiple sclerosis,... more

Decline in PCI for STEMI yet to return to pre-pandemic levels

Posted on May 21, 2022

ATLANTA — The monthly rate of PCI for STEMI dropped steadily at the start of the COVID-19 pandemic and has yet to... more

Long-term clopidogrel confers less MACCE, bleeding events vs. aspirin after PCI

Posted on May 20, 2022

ATLANTA — Clopidogrel monotherapy after 12 months of event free post-PCI dual antiplatelet therapy was associated with fewer MACCE and bleeding events... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  •   Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  •   Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more

  •   Sang Hong Baek

    VP/President Elect

    Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more

  •   Georg Noll


      Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more